日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / China-US

China-US cooperation combating breast cancer launched

chinadaily.com.cn | Updated: 2018-06-26 11:44
Share
Share - WeChat

The breast cancer center of Guangdong Academy of Medical Sciences & Guangdong General Hospital has recently been recognized by the National Surgical Adjuvant Breast and Bowel Project (NSABP) from the US as its first official partner in China.

The latest inclusion was announced at the 2018 China-America Summit Forum on Surgical Oncology and 2018 China-America Summit Forum on Breast Cancer in Guangzhou, capital city of south Guangdong province in mid June.

Liao Ning delivers a presentation at the 3rd China-America Summit Forum on Breast Cancer in Guangzhou on Jun 16. [provided to chinadaily.com.cn]

Liao Ning, head of the center said: "As an NSABP affiliated member, we can participate in more global research in breast cancer and better present Chinese patients in international researches in a bid to advance treatment and prevention of the disease worldwide," she said.

China reported more than 260,000 new cases of breast cancer annually, accounting for about 15 percent of all new cases of cancer every year, statistics from the Chinese National Central Cancer Registry showed.

The data from Chinese patients is crucial for cancer drug research and development internationally as well, she said.

"The cooperation will be of mutual benefits for both sides and represents a start of wider and deepen collaboration in the future to better contain breast cancer," she said.

Charles Balch, President of the International Sentinel Node Society and former executive vice president and CEO of the American Society of Clinical Oncology, said: "This brings China in as a full partner at the world stage to do clinical trials globally with NSAPB."

Liao and her team would have access into the global clinical trials with investigators worldwide and “her data from China would contribute to global research and clinical trials of breast cancer, he explained.

According to Balch, NSABP had seen over the past two years the quality and excellence of the breast cancer care and research at the center and deter and decided to include it as its affiliated member.

Liao Ning (center) and foreign delegates at the forum [Provided to chinadaily.com.cn]

"And I hope it will be so successful that other major projects doing breast cancer clinical trials in China would apply to be approved as NSABP affiliated members as well," he added.

In March, Liao Ning was elected as the International Director of the American Society of Oncology Surgery, which means that the hospital has been in line with international standards in the surgical treatment of breast cancer, including axillary sentinel lymph node biopsy, breast conserving breast surgery and breast reconstruction, according to Geng Qingshan, Party Secretary of Guangdong General Hospital.

"The hospital will vigorously support the follow-up cooperation between the breast cancer center led by Liao and international research and clinical organizations, and jointly explore a scientific and comprehensive multidisciplinary treatment model to benefit more breast cancer patients," he said.

Regarding the latest NSABP inclusion, Geng said: "In April 2018, our hospital submitted the application and after strict examination, we became China's first NSABP member of the main research unit. This is the result of our joint efforts.

I hope that we will continue to deepen cooperation and jointly promote human health in the future."

As the clinical intervention of breast cancer enters into the new stage of targeting therapy and precision medicine, “international cooperation and data sharing is of greater importance for better treatment and cancer drug research and development,” said Liao Ning, who has been committed to breast cancer surgical treatment for nearly 30 years.

The National Surgical Adjuvant Breast and Bowel Project (NSABP) based in the US is a clinical trials cooperative group supported since its inception by the US National Cancer Institute.

It has a more than 50-year history of designing and conducting clinical trials that have changed the way breast cancer is treated, and, more recently, prevented.

Notably, it was the NSABP's breast cancer studies that led to the establishment of lumpectomy plus radiation over radical mastectomy as the standard surgical treatment for breast cancer worldwide.

Headquartered in Pittsburgh, Pennsylvania, it has research sites at nearly 1000 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the US, Canada, Puerto Rico, Australia, and Ireland.

At those sites and their satellites, more than 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲黄区| 一级看片免费视频 | 97精品国产高清久久久久蜜芽 | 一区在线播放 | 天天干天天操天天做 | 欧美日本国产 | 国产一区不卡 | 素人视频免费观看 | 久久久婷 | 国产精品久久福利新婚之夜 | 国产精品乱码人人做人人爱 | 毛片搜索 | 色综合亚洲色综合久久网张柏芝 | 久久久不卡网国产精品一区 | 色婷婷导航 | 亚洲天堂视频在线观看 | 成人黄色在线视频 | 欧美成人精品一区二区三区 | 一区二区三区在线看 | 色婷婷久久久亚洲一区二区三区 | 久久国内精品 | 五月天激情视频 | 欧美性野久久久久久久久 | 亚洲欧洲一区二区 | 国产精品v欧美精品∨日韩 一级免费黄色免费片 | 日韩欧美在线免费观看视频 | 久久一区二区三区免费播放 | 2022国产91精品久久久久久 | 色中文网 | 亚洲精品成人AA片在线播 | 奇米777视频 | 爱爱爱av | 良妾很能生 | 国产欧美日韩精品一区 | 国产91久久最新观看地址 | 免费a视频在线观看 | 人人澡人人澡人人澡 | 精品毛片| 中文字幕av一区二区 | 亚洲欧洲av在线 | 欧美一区二区三区四区夜夜大片 |